Ravasio R, Rigo F, Lattuada E, et al. The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients. Farmeconomia. Health Economics and Therapeutic Pathways. 2017;18(1). https://doi.org/10.7175/fe.v18i1.1325